glp-1 fda approval Lilly is now pharma's top revenue company. It just got for an oral GLP-1, but Wall Street isn't celebrating FDA Approves First Generic GLP-1
Description
CSE, Chinese Society of Endocrinology

Moens K, Heimberg H, Flamez D et al

Independent analytical laboratories test the actual product and report results with no financial incentive to inflate quality claims

Oprah reveals that her food noise also returned when she stopped the medication

Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet

A number of studies dedicated to GLP-1RA efficacy in T2D included patients with chronic HF (CHF) (16.2% in the EXSCEL trial, 23.6% in SUSTAIN-6, 12.2% in PIONEER, 8.6% in REWIND, 20% in Harmony, 22% in ELIXA and 18% in LEADER)
